tiprankstipranks
Aziyo Biologics Gains FDA Clearance for EluPro® Bioenvelope
Company Announcements

Aziyo Biologics Gains FDA Clearance for EluPro® Bioenvelope

Don't Miss our Black Friday Offers:

An update from Aziyo Biologics (ELUT) is now available.

Elutia Inc. announced that their new product, EluPro®, previously known as CanGaroo®RM, has received FDA clearance. This antibiotic-eluting bioenvelope represents a significant milestone for the company, potentially impacting its stock as it marks a major regulatory success. The announcement could signal a positive shift for investors and those tracking the pharmaceutical sector.

Learn more about ELUT stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskElutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch
TheFlyElutia reports Q3 EPS (33c) vs (57c) last year
Christine BrownELUT Upcoming Earnings Report: What to Expect?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App